59 -11 (61) 2023 — Aslonova M.R. — DEVELOPMENT OF SEVERITY INDICATORS IN THE ASSOCIATION OF SARS-CОV-2 PNEUMONIA WITH TYPE 2 DIABETES

DEVELOPMENT OF SEVERITY INDICATORS IN THE ASSOCIATION OF SARS-CОV-2 PNEUMONIA WITH TYPE 2 DIABETES

Aslonova M.R.  Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

This new approach to diagnosing patients with SARS CoV-2 pneumonia associated with type 2 diabetes mellitus, with calculation of the severity of the patient’s condition, allows for timely diagnosis, differential diagnosis and determination of treatment tactics, as well as transfer to an intensive care unit for intensive treatment.

Key words: SARS CoV-2, pneumonia, type 2 diabetes mellitus, pneumonia, interferon, cytokine.

First page

364

Last page

368

For citation: Aslonova M.R. – DEVELOPMENT OF SEVERITY INDICATORS IN THE ASSOCIATION OF SARS-CОV-2 PNEUMONIA WITH TYPE 2 DIABETES //New Day in Medicine 2023 11(61): 364-368 https://newdaymedicine.com/index.php/2023/11/30/l-547/

LIST OF REFERENCES:

1. Аслонова М.Р., (2023). Сorrelation Relationship of Interferons, Cytokines with Biochemical Mediators of Inflammation in The Blood in The Association of Covid-19 and Type 2 Diabetes // Texas Journal of Medical Science. 2023;26:26-32.
2. Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti// Practical recommendations for the management of diabetes in patients with COVID-19 Lancet Diabetes Endocrinol // 2020 Jun;8(6):546-550.
3. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y. Cochrane COVID-19 Diagnostic Test Accuracy Group. 2020. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev 7:CD013665. 10.1002/14651858.CD013665
4. World Health Organization Naming the coronavirus disease (COVID-19) and the virus that causes it [EB/OL] 2020;2-11.
5. World Health Organization. 2021. WHO Coronavirus (COVID-19) Dashboard. Accessed Apr. 16, 2021. 
6. Аслонова М.Р., (2023). Оценка интерферонового статуса у пациентов с сахарным диабетом 2 типа, инфицированных covid-19 // Журнал гуманитарных и естественных наук. 2023;3(9):196-202.
7. Облокулов А.Р., Ниезов Г.Э., Ражабов А.Р. (2021). Cовид-Ассоциированная Коагулопатия У Пациентов Новой Коронавирусной Инфекции. // Central asian journal of medical and natural sciences, 2021;124-130.
8. Облоқулов А.Р., Ниёзов Г.Е., Елмуродова А.А., Орифов Д.У. (2020). Clinical characteristics of patients with COVID-19. // Interdisciplinary Approaches to Medicine, 2020;1(2):40-43.
9. Пономарева А.А. 2 Прогностические факторы риска клинических исходов пациентов с сахарным диабетом 2 типа и новой коронавирусной инфекцией // Эндокринология: новости, мнения, обучение. 2021;10(3):106-108.
10. Хайдарова Ф.А., Алиева А.В., Бердыкулова Д.М., Алимова Н.У., Халилова Д.З., Тожиева И.М. Структура смертности среди пациентов с сахарным диабетом в Республике Узбекистан во время пандемии COVID-19 // Сахарный диабет. 2022;25(4):322-326.